0000000000201023

AUTHOR

Filippos Kesisoglou

showing 3 related works from this author

In vitro models for the prediction of in vivo performance of oral dosage forms: Recent progress from partnership through the IMI OrBiTo collaboration

2019

The availability of in vitro tools that are constructed on the basis of a detailed knowledge of key aspects of gastrointestinal (GI) physiology and their impact on formulation performance and subsequent drug release behaviour is fundamental to the success and efficiency of oral drug product development. Over the last six years, the development and optimization of improved, biorelevant in vitro tools has been a cornerstone of the IMI OrBiTo (Oral Biopharmaceutics Tools) project. By bringing together key industry and academic partners, and by linking tool development and optimization to human studies to understand behaviour at the formulation/GI tract interface, the collaboration has enabled …

Process managementUPPER GASTROINTESTINAL-TRACTAdministration OralPharmaceutical Science02 engineering and technologyWATER DIFFUSIVITYModels Biological030226 pharmacology & pharmacyDosage formBiopharmaceutics03 medical and health sciences0302 clinical medicineDISINTEGRATION TESTERHumansPharmacology & PharmacyWEAK BASESIntersectoral CollaborationBiologyTEST DEVICEDosage FormsALBENDAZOLE CONCENTRATIONSScience & TechnologyHuman studiesbusiness.industryBiopharmaceuticsFED STATE CONDITIONSGeneral Medicine021001 nanoscience & nanotechnologyRELEASE TABLETSGastrointestinal TractPharmaceutical PreparationsGastrointestinal AbsorptionGeneral partnershipSOLID DISPERSIONNew product developmentDrug releaseIntersectoral Collaboration0210 nano-technologybusinessLife Sciences & BiomedicineUPPER SMALL-INTESTINEOral retinoidForecastingBiotechnology
researchProduct

A survey on IVIVC/IVIVR development in the pharmaceutical industry – Past experience and current perspectives

2017

The present work aimed to describe the current status of IVIVC/IVIVR development in the pharmaceutical industry, focusing on the use and perception of specific approaches as well as successful and failed case studies. Two questionnaires have been distributed to 13 EFPIA partners of the Oral Biopharmaceutics Tools Initiative and to the Pharmacokinetics Working Party of the European Medicines Agency in order to capture the perspectives and experiences of industry scientists and agency members, respectively. Responses from ten companies and three European Agencies were received between May 21st 2014 and January 19th 2016. The majority of the companies acknowledged the importance of IVIVC/IVIVR…

Drug IndustryOperations researchPharmaceutical Science02 engineering and technologyModels Biological030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineIVIVCSurveys and QuestionnairesDrug DiscoveryAgency (sociology)AnimalsHumansRelevance (law)MedicinePharmacokineticsMarketingPharmaceutical industryRate of returnFlexibility (engineering)business.industry021001 nanoscience & nanotechnologyDrug developmentPositive attitude0210 nano-technologybusinessEuropean Journal of Pharmaceutical Sciences
researchProduct

Optimization of the Ussing chamber setup with excised rat intestinal segments for dissolution/permeation experiments of poorly soluble drugs.

2016

AbstractContext: Prediction of the in vivo absorption of poorly soluble drugs may require simultaneous dissolution/permeation experiments. In vivo predictive media have been modified for permeation experiments with Caco-2 cells, but not for excised rat intestinal segments.Objective: The present study aimed at improving the setup of dissolution/permeation experiments with excised rat intestinal segments by assessing suitable donor and receiver media.Methods: The regional compatibility of rat intestine in Ussing chambers with modified Fasted and Fed State Simulated Intestinal Fluids (Fa/FeSSIFmod) as donor media was evaluated via several parameters that reflect the viability of the excised in…

Cell Membrane PermeabilityPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyBile Acids and Salts03 medical and health sciences0302 clinical medicineIn vivoDrug DiscoveryAnimalsHumansDissolutionPharmacologyRat intestineChromatographyUssing chamberChemistryOrganic ChemistryIn vivo absorptionPermeation021001 nanoscience & nanotechnologyRatsIntestinesJejunumSolubilityCaco-2 Cells0210 nano-technologyFederal stateDrug development and industrial pharmacy
researchProduct